Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Then it will be around the time of ASCO. I was wondering if that was the reason that NWBO would have no presentation at the Industry Expert Theater this year.
https://conferences.asco.org/am/industry-expert-theater
How could you use someone's account? Is it allowed on this board? I should report you that you imply my orientation and mental state.
You talk just like that inquiring poster. How much did the real Nemesis pay you?
What do you think of a company with its founder using poly-iclc to fight HIV, cancer and other infectious diseases while doing a lot of research on CYT107 from RevImmune?
Even don't know how to lie. Definitely in panic mode.
Good luck to you!
I think you read the news already.
https://www.uclahealth.org/news/release/adding-immune-boosting-agent-personalized-cancer-vaccine
IC,
You seem like in panic mode. Take care of your stress. You said you are a cancer survivor. Here is a good article for you.
Study Suggests a Link between Stress and Cancer Coming Back
https://www.cancer.gov/news-events/cancer-currents-blog/2021/cancer-returning-stress-hormones
Copying and pasting is great. It means I don't put BS on this board. It means what I post is authentic. Get it?
Have I reminded you since last year what you were trying to do would doom? I provided you series of genuine DDs to convince you to bail. But you would not listen. Fraudstein must have brainwashed you very bad. Keep in mind my Boma is yours now.
Doc,
While I was trying to take a look at one of Oncovir's partners, I found this French company called LinkinVax, the interesting part is that the founder of the company is Levy Yves who did plenty research on CYT107. He also happened to be the program coordinator for the research project by the Vaccine Research Institute. Seems like they are all connected in some way. Just something fun to share.
Thanks for the link
Yeah! I have been advocating this idea all the time. This is the minimum. RA may give guidance on the combination use of keytruda.
BTW, is it possible that NWBO also has a drug master file with the FDA like the one Oncovir has?
IC,
The Nature paper is just the beginning. The case study paper was accepted for publication. The following paper could be published anytime too which could be more significant since never before NCI top-notch scientists did such type of analysis on samples from a phase 3 trial totally run by a company. The implications are significant. The paper on the combo trial should be published this year. Likewise a paper from the highly secrete colorectal trial. Here are the words from the JAMA paper. Seems to me there could be another paper.
BTW, I mentioned Professor Lisa Butterfield. I think you didn't pay any attention.
Professor Lisa Butterfield is a well-renowned scientist on dendritic cell vaccine too. She used to be the chair of Cellular, Tissues and Gene Therapies Advisory Committee of FDA for four years before she joined Merck last March. She ran a clinical trial using her own version of DC vaccine on melanoma. But she didn't make any breakthrough. Together with Antoni Ribas, she published plenty papers dendritic cells and immunotherapy. I really doubt that Merck would develop its own DC vaccine since the patent wall built by LP over the past many years would block any BP from such an attempt.
Immuno-metabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients
https://www.nature.com/articles/s41467-023-42881-4
Multiple Antigen-Engineered DC Vaccine for Melanoma
https://clinicaltrials.gov/study/NCT01622933?cond=NCT01622933&rank=1
https://scholar.google.com/scholar?hl=en&as_sdt=0%2C44&q=Lisa+butterfield+%2B+Antoni+Ribas&btnG=
IC,
Once you are homeless, you can use my Boma for free. PM taught me about how to build one. You can double check with him.
I can feel there is close coordination between NWBO and Oncovir.
Your boss IP is from UK. What's yours? From the post I read before, you are in Georgia. Right?
I have enough exchange with you now. You are a lightweight. Not worthy of my time. Give back the account to your hypocrite billionaire boss.
My bad, misfire then.
Think about what happened when the preprint was out. If you were an institutional investor and you happened to read the paper, would you throw big money right away? The answer is no. You would read it and you would call experts to collect their opinions and you would have several rounds of meetings and discussions. You may reach LP directly to see if you can load more shares in a cheap way. Is it supposed to be this procedure?
Just so you know. I have no interest in you. Your boss, that hypocrite billionaire is the one I am interested. You can rat him out and come to Laura as a whistle blower if you want to get rich fast.
So now you know that it is possible NWBO longs may give credit to my posts. I am certain every NWBO long will pay no attention to your BS.
Everyone needs to read it and digest it first. I know for a fact you never read it even though the preprint has been there since last August. That's why you are on the wrong side of the history.
Stupid minion. Never learned a thing. Change your user name.
Thank you, Dude. I should buy you beer if by any chance I meet you.
I need to expose who you are. But more importantly, I want LP, Coffer Black, and Laura Posner to take a look too. Have you asked yourself how Laura Posner could download 235,194 posts? She must have the court order. Along with these posts are the IP address. Your boss has IP address from UK. Ask yourself what is your IP address. You can ask Ex who knows better in this regard.
NWBO longs,
Send anything that you think Laura Posner might have interest investigating further.
Laura H. Posner
Michael B. Eisenkraft
COHEN MILSTEIN SELLERS & TOLL PLLC
88 Pine Street, 14th Floor
New York, New York 10005
Tel: (212) 838-7797
Fax: (212) 838-7745
lposner@cohenmilstein.com
meisenkraft@cohenmilstein.com
Raymond M. Sarola (RS1010)
Cohen Milstein Sellers & Toll PLLC
100-120 N. 18th Street, Suite 1820
Philadelphia, PA 19103
Tel: (267) 479-5700
Fax: (267) 479-5701
rsarola@cohenmilstein.com
He most likely got the medical record from someone else. I really question if he did it with the patient's consent. Laura Posner can find out.
Bravo!! bio, you nailed him.
He used to think of himself as the largest retailer of NWBO. But it seems like suppressing NWBO can make him more than holding it.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157574329
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165281637
Just a reminder, your boss likes using the word "mate" a lot.
Now he hires a low-level minion to handle his account.
Just wonder if this presentation is related to the case study paper mentioned by NWBO and accepted for publication.
Tumour Regression Following DCVax-L Immunotherapy: An Illustrated Case Report
https://www.sbns.org.uk/index.php/download_file/view/2338
Dude,
Great post!
Radio silence means NWBO is preparing for big war.
What did Warren Buffet say?
Have you checked out all the papers from Dr. Liau which have all the data uploaded to GEO DataSets? Obviously, you haven't.
Here is the link of all the papers. Go through each of them before you roll the dice and post nonsense.
https://www.ncbi.nlm.nih.gov/gds/?term=Liau%20LM
Fabulous post! Agree with you totally about the following.
I feel like the acquisition deal of Prometheus by Merck may give us some rough estimate on the value of NWBO.
The size UC and CD market is about $23b in 2022 and Merck spent about half of $23b on BO. Note that Prometheus didn't have phase 3 trial. The solid tumor market is between $200b and $300b I suspect. The value of NWBO should be a big number.
https://s21.q4cdn.com/488056881/files/doc_presentations/2023/04/Splash-Investor-Event-Slides-FINAL-1.pdf
I only found there was a change on date.
https://classic.clinicaltrials.gov/ct2/history/NCT04201873?A=8&B=9&C=Side-by-Side#StudyPageTop
Has anyone noticed there was an update on the combo trial?
https://clinicaltrials.gov/study/NCT04201873?cond=atl-dc&rank=1
I can guarantee you this is not my last response to you. But you haven't been honest with the simple fact that you are whosleftholdindabag, a billionaire holding NVCR.